reglab/housing_qa huggingface dataset:
NM Stat § 24-1J-6 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 1J - County and Tribal Health Councils|Section 24-1J-6 - Department; powers and duties.

The department shall:A. in consultation with health councils, develop benchmarks, expectations and mechanisms to ensure the long-term viability of health councils;B. in collaboration with universities, other state agencies and other public health entities, provide training, technical assistance and other supports to health councils;C. in collaboration with other entities, develop a system to evaluate the effectiveness of health councils and the gathering of necessary evaluation data; D. administer funding to support the work of the health councils, including local health council staffing, training and technical assistance, and monitor and evaluate contracts for funding; andE. adopt and promulgate rules as necessary to carry out the purposes of the County and Tribal Health Councils Act and to strengthen community-based health planning and self-determination.History: Laws 2019, ch. 57, § 6. ANNOTATIONSEffective dates. — Laws 2019, ch. 57 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 14, 2019, 90 days after the adjournment of the legislature.
NM Stat § 24-1K-1 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 1K - Primary Care Council|Section 24-1K-1 - Short title.

This act [24-1K-1 to 24-1K-3 NMSA 1978] may be cited as the "Primary Care Council Act".History: Laws 2021, ch. 87, § 1. ANNOTATIONSEffective dates. — Laws 2021, ch. 87 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 18, 2021, 90 days after adjournment of the legislature.
NM Stat § 24-1K-2 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 1K - Primary Care Council|Section 24-1K-2 - Definitions.

As used in the Primary Care Council Act:A. "department" means the human services department;B. "primary care" means integrated, accessible health care services, provided by clinicians accountable for addressing the majority of a patient's personal health care needs, developing a sustained partnership with patients and practicing in the context of family and community; andC. "secretary" means the secretary of human services.History: Laws 2021, ch. 87, § 2. ANNOTATIONSEffective dates. — Laws 2021, ch. 87 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 18, 2021, 90 days after adjournment of the legislature.
NM Stat § 24-2-1 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2 - Crippled Children Services|Section 24-2-1 - Authority to conduct services for children with a disability.

The public health division of the department of health has authority to establish, administer and supervise activities to children who have a physical disability or whose condition may become a disability. The public health division also may supervise the administration of those services to children with a disability that are not administered directly by it. History: 1978 Comp., § 24-2-1, enacted by Laws 1977, ch. 253, § 40; 2007, ch. 46, § 14. ANNOTATIONSThe 2007 amendment, effective June 15, 2007, made non-substantive language changes.
NM Stat § 24-2A-1 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2A - Hemophilia Program|Section 24-2A-1 - Short title.

This act [24-2A-1 to 24-2A-3 NMSA 1978] may be cited as the "Theodore R. Montoya Memorial Hemophilia Program Act". History: Laws 1980, ch. 26, § 1.
NM Stat § 24-2A-2 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2A - Hemophilia Program|Section 24-2A-2 - Definitions.

As used in the Theodore R. Montoya Memorial Hemophilia Program Act: A. "blood products" means certain components or factors obtained from whole blood which when periodically administered to persons suffering from hemophilia result in relief or control of the disease; B. "eligible patient" means a person suffering from hemophilia whose case has been evaluated and accepted for provision of services by the hemophilia program established by the school; C. "fund" means the hemophilia fund; D. "hemophilia" means a genetic disease in which uncontrolled bleeding from otherwise minor causes may result in death or disability; E. "hemophilia program" means the New Mexico comprehensive hemophilia diagnostic and treatment program established by the school to provide comprehensive clinical evaluation of patients suffering from hemophilia, out-patient blood product usage, counseling services to families of persons suffering from hemophilia and outreach to the public; F. "provider" means any blood service or laboratory furnishing blood products to the school and its program administration for eligible patients; G. "university" means the university of New Mexico; and H. "secretary" means the secretary of health and environment [secretary of health]. History: Laws 1980, ch. 26, § 2. ANNOTATIONSBracketed material. — The bracketed material was inserted by the compiler and is not part of the law. Laws 1991, ch. 25, § 16 repealed former 9-7-4 NMSA 1978, relating to the health and environment department and enacted a new 9-7-4 NMSA 1978 which created the department of health. Section 9-7-5 NMSA 1978, as amended by Laws 1991, ch. 25, § 17, made the secretary of health the administrative head of the department.
NM Stat § 24-2A-3 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2A - Hemophilia Program|Section 24-2A-3 - Hemophilia fund created; use; calculation of costs.

A. There is created in the state treasury the "hemophilia fund". B. The fund shall be administered by the university and shall be used solely to provide hemophilia program services to eligible patients. The university may expend and distribute funds to: (1) the university of New Mexico school of medicine for the costs of clinical evaluation, to include at least one visit per eligible patient per year; (2) providers for the costs of blood products for each eligible patient, all as approved by the university of New Mexico school of medicine, to the extent not covered by insurance, medicaid or medicare; (3) the university of New Mexico school of medicine for hemophilia program support, including nursing coordination, social services to patients and families and outreach for public education; and (4) the university of New Mexico school of medicine for purchase of insurance or medicare coverage for patients who are eligible for coverage but have insufficient financial resources to pay the premiums. History: Laws 1980, ch. 26, § 3; 2001, ch. 308, § 1. ANNOTATIONSThe 2001 amendment, effective June 15, 2001, inserted the university of New Mexico school of medicine throughout the section and added Paragraph B(4).
NM Stat § 24-2B-1 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-1 - Short title.

Chapter 24, Article 2B NMSA 1978 may be cited as the "Human Immunodeficiency Virus Test Act". History: Laws 1989, ch. 227, § 1; 1993, ch. 107, § 1. ANNOTATIONSThe 1993 amendment, effective July 1, 1993, substituted "Chapter 24, Article 2B NMSA 1978" for "This act". Am. Jur. 2d, A.L.R. and C.J.S. references. — Child custody and visitation rights of person infected with AIDS, 86 A.L.R.4th 211. Transmission or risk of transmission of human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) as basis for prosecution or sentencing in criminal or military discipline case, 13 A.L.R.5th 628. Validity and propriety under circumstances, of court-ordered HIV testing, 87 A.L.R.5th 631. The Propriety, under ERISA (29 USCS § 1001 et seq.) and the Americans With Disabilities Act (42 USCS § 12101 et seq.), of Capping Health Insurance Coverage for HIV-Related Claims, 131 A.L.R. Fed. 191.
NM Stat § 24-2B-2 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-2 - Informed consent.

No person shall perform a test designed to identify the human immunodeficiency virus or its antigen or antibody without first obtaining the informed consent of the person upon whom the test is performed, except as provided in Section 24-2B-5, 24-2B-5.1, 24-2B-5.2 or 24-2B-5.3 NMSA 1978. Informed consent shall be preceded by an explanation of the test, including its purpose, potential uses and limitations and the meaning of its results. Consent need not be in writing if there is documentation in the medical record that the test has been explained and the consent has been obtained. The requirement for full pre-test counseling may be waived under the following circumstances: A. the performance of a prenatal test to determine if the human immunodeficiency virus or its antigen is present in a pregnant woman; provided that the woman, or her authorized representative, after having been informed of the option to decline the human immunodeficiency virus test, may choose not to have the human immunodeficiency virus test performed as a part of the routine prenatal testing if she or her authorized representative provides a written statement as follows: "I am aware that a test to identify the human immunodeficiency virus or its antigen or antibody is a part of routine prenatal testing. However, I voluntarily and knowingly choose not to have the human immunodeficiency virus test performed. _______________________________________________ (Name of patient or authorized representative) _______________________________________________ (Signature and date)."; or B. when human immunodeficiency virus testing is part of routine medical care. History: Laws 1989, ch. 227, § 2; 1993, ch. 107, § 2; 1996, ch. 80, § 7; 2000, ch. 36, § 1; 2007, ch. 108, § 1. ANNOTATIONSThe 2007 amendment, effective June 15, 2007, provided that the requirement for immunodeficiency pre-test counseling may be waived if the human immunodeficiency virus test is part of routine medical care or if the test is performed as part of a routine prenatal test, unless the pregnant woman chooses not to have the test performed. The 2000 amendment, effective May 17, 2000, inserted "or 24-2B-5.3" in the first sentence. The 1996 amendment, effective July 1, 1996, inserted "or 24-2B-5.2 NMSA 1978" following "24-2B-5.1" and made a stylistic change in the first sentence. The 1993 amendment, effective June 18, 1993, substituted "24-2B-5 or 24-2B-5.1 NMSA 1978" for "6 of the Human Immunodeficiency Virus Test Act" in the first sentence. Am. Jur. 2d, A.L.R. and C.J.S. references. — Damage action for HIV testing without consent of person tested, 77 A.L.R.5th 541.
NM Stat § 24-2B-3 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-3 - Substituted consent.

Informed consent shall be obtained from a legal guardian or other person authorized by law when the person is not competent. A minor shall have the capacity to give informed consent to have the human immunodeficiency virus test performed on himself. History: Laws 1989, ch. 227, § 3.
NM Stat § 24-2B-4 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-4 - Mandatory counseling.

No positive test result shall be revealed to the person upon whom the test was performed without providing or referring that person for individual counseling about: A. the meaning of the test results; B. the possible need for additional testing; C. the availability of appropriate health care services, including mental health care, social and support services; and D. the benefits of locating and counseling any individual by whom the infected person may have been exposed to the human immunodeficiency virus and any individual whom the infected person may have exposed to the human immunodeficiency virus. History: Laws 1989, ch. 227, § 4; 2013, ch. 72, § 1. ANNOTATIONSThe 2013 amendment, effective March 29, 2013, eliminated the requirement that a person upon whom a positive immunodeficiency virus test has been performed be provided or referred to counseling; and after "performed without", deleted "the person performing the test or the health facility at which the test was performed".
NM Stat § 24-2B-5 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-5 - Informed consent not required.

Informed consent for testing is not required and the provisions of Section 24-2B-2 NMSA 1978 do not apply for: A. a health care provider or health facility performing a test on the donor or recipient when the health care provider or health facility procures, processes, distributes or uses a human body part, including tissue and blood or blood products, donated for a purpose specified under the Uniform Anatomical Gift Act [repealed] or for transplant recipients or semen provided for the purpose of artificial insemination and the test is necessary to ensure medical acceptability of a recipient or the gift or semen for the purposes intended; B. the performance of a test in bona fide medical emergencies when the subject of the test is unable to grant or withhold consent and the test results are necessary for medical diagnostic purposes to provide appropriate emergency care or treatment, except that post-test counseling or referral for counseling shall nonetheless be required when the individual is able to receive that post-test counseling. Necessary treatment shall not be withheld pending test results; C. the performance of a test for the purpose of research if the testing is performed in a manner by which the identity of the test subject is not known and may not be retrieved by the researcher; or D. the performance of a test done in a setting where the identity of the test subject is not known, such as in public health testing programs and sexually transmitted disease clinics. History: Laws 1989, ch. 227, § 5; 2000, ch. 36, § 2; 2003, ch. 342, § 1; 2007, ch. 108, § 2. ANNOTATIONSBracketed material. — The bracketed material was inserted by the compiler and is not part of the law. Laws 2007, ch. 323, § 35 repealed the Uniform Anatomical Gift Act, effective July 1, 2007. For comparable provisions, see Chapter 24, Article 6B, the Jonathan Spradling Revised Uniform Anatomical Gift Act. Cross references. — For waiver of immunodeficiency virus test, see 24-2B-2 NMSA 1978. The 2007 amendment, effective June 15, 2007, eliminated the waiver of informed consent for testing if the human immunodeficiency virus test is performed as part of routine medical care or as a routine prenatal test, unless the pregnant woman chooses not to have the test performed. The 2003 amendment, effective June 20, 2003, added Subsection E. The 2000 amendment, effective May 17, 2000, substituted "Section 24-2B-2 NMSA 1978" for "Section 1 of the Human Immunodeficiency Virus Test Act" in the preliminary language of the section, deleted former Subsection D, concerning the testing of health care workers, and redesignated former Subsection E as Subsection D.
NM Stat § 24-2B-5.3 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-5.3 - Informed consent not required; testing of persons who are source individuals.

A. As used in this section: (1) "exposed individual" means a health care provider, first responder or other person, including an employee, volunteer or independent contracted agent of a health care provider or law enforcement agency, while acting within the scope of his employment; or a person who, while receiving services from a health care provider, is significantly exposed to the blood or other potentially infectious material of another person, when the exposure is proximately the result of the activity of the exposed individual or receipt of health care services from the source individual; (2) "significantly exposed" means direct contact with blood or other potentially infectious material of a source individual in a manner that is capable of transmitting the human immunodeficiency virus; and (3) "source individual" means a person whose blood or other potentially infectious material may have been or has been the source of a significant exposure. B. A test designed to identify the human immunodeficiency virus or its antigen or antibody may be performed without the consent of a source individual when an exposed individual is significantly exposed. C. If consent to perform a test on a source individual cannot be obtained pursuant to the provisions of Section 24-2B-2 or 24-2B-3 NMSA 1978, the exposed individual may petition the court to order that a test be performed on the source individual; provided that the same test shall first be performed on the exposed individual. The test may be performed on the source individual regardless of the result of the test performed on the exposed individual. If the exposed individual is a minor or incompetent, the parent or guardian may petition the court to order that a test be performed on the source individual. D. The court may issue an order based on a finding of good cause after a hearing at which both the source individual and the exposed individual have the right to be present. The hearing shall be conducted within seventy-two hours after the petition is filed. The petition and all proceedings in connection with the petition shall be under seal. The test shall be administered on the source individual within three days after the order for testing is entered. E. The results of the test shall be disclosed only to the source individual and the exposed or the exposed individual's parent or guardian. When the source individual or the exposed individual has a positive test result, both shall be provided with counseling as provided in Section 24-2B-4 NMSA 1978. History: 1978 Comp., § 24-2B-5.3, enacted by Laws 2000, ch. 36, § 3. ANNOTATIONS
NM Stat § 24-2B-7 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-7 - Disclosure statement.

No person to whom the results of a test have been disclosed may disclose the test results to another person except as authorized by the Human Immunodeficiency Virus Test Act. Whenever disclosure is made pursuant to that act, it shall be accompanied by a statement in writing that includes the following or substantially similar language: "This information has been disclosed to you from records whose confidentiality is protected by state law. State law prohibits you from making any further disclosure of such information without the specific written consent of the person to whom such information pertains, or as otherwise permitted by state law. A person who makes an unauthorized disclosure of this information is guilty of a petty misdemeanor and shall be sentenced to imprisonment in the county jail for a definite term not to exceed six months or the payment of a fine of not more than five hundred dollars ($500), or both." History: Laws 1989, ch. 227, § 7; 1996, ch. 80, § 9. ANNOTATIONSThe 1996 amendment, effective July 1, 1996, added the second sentence to the quoted language and made a stylistic change in the second sentence. Law reviews. — For comment, "Sex, Lies, and Lawsuits: A New Mexico Physician's Duty to Warn Third Parties Who Unknowingly May Be At Risk of Contracting HIV From a Patient," see 26 N.M.L. Rev. 481 (1996).
NM Stat § 24-2B-8 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-8 - Disclosure.

Nothing in the Human Immunodeficiency Virus Test Act shall be construed to prevent a person who has been tested from disclosing in any way to any other person his own test results. Any victim of an alleged criminal offense who receives information pursuant to Section 24-2B-5.2 NMSA 1978 may disclose the test results as is reasonably necessary to protect his health and safety or the health and safety of his family or sexual partner. History: Laws 1989, ch. 227, § 8; 1996, ch. 80, § 10. ANNOTATIONSThe 1996 amendment, effective July 1, 1996, substituted "Disclosure" for "Self-disclosure" in the section head and added the last sentence.
NM Stat § 24-2B-9 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2B - Human Immunodeficiency Virus Tests|Section 24-2B-9 - Penalty.

A person who makes an unauthorized disclosure of the results of a test designed to identify the human immunodeficiency virus or its antigen or antibody is guilty of a petty misdemeanor and shall be sentenced to imprisonment in the county jail for a definite term not to exceed six months or the payment of a fine of not more than five hundred dollars ($500), or both. History: 1978 Comp., § 24-2B-9, enacted by Laws 1996, ch. 80, § 11.
NM Stat § 24-2C-1 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2C - Harm Reduction|Section 24-2C-1 - Short title.

Sections 1 through 6 [24-2C-1 to 24-2C-6 NMSA 1978] of this act may be cited as the "Harm Reduction Act". History: Laws 1997, ch. 256, § 1.
NM Stat § 24-2C-2 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2C - Harm Reduction|Section 24-2C-2 - Purpose.

The purpose of the Harm Reduction Act is to: A. prevent the transmission of the human immunodeficiency virus, hepatitis B and C viruses and other blood-borne diseases; and B. encourage intravenous drug users to seek substance abuse treatment and ensure that participants receive individual counseling and education to decrease the risk of transmission of blood-borne diseases. History: Laws 1997, ch. 256, § 2.
NM Stat § 24-2C-3 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2C - Harm Reduction|Section 24-2C-3 - Definitions.

As used in the Harm Reduction Act: A. "department" means the department of health; B. "participant" or "client" means an intravenous drug user who exchanges a used hypodermic syringe, needle or other object used to inject controlled substances or controlled substance analogs into the human body for a sterile hypodermic syringe and needle in compliance with the procedures of the program; and C. "program" means a harm reduction program for the purpose of sterile hypodermic syringe and needle exchange. History: Laws 1997, ch. 256, § 3.
NM Stat § 24-2C-4 (2021)
2021 New Mexico Statutes|Chapter 24 - Health and Safety|Article 2C - Harm Reduction|Section 24-2C-4 - Program created; department responsibilities.

A. The department shall: (1) establish and administer a harm reduction program for the purpose of sterile hypodermic syringe and needle exchange; (2) compile data to assist in planning and evaluating efforts to combat the spread of blood-borne diseases; and (3) make an annual report, including legislative recommendations, to the legislative health and human services committee by October 1 each year. B. Within thirty days of the effective date of the Harm Reduction Act, the department shall appoint an advisory committee, to include representation from: (1) the office of the attorney general; (2) the New Mexico state police division of the department of public safety; (3) the human immunodeficiency virus sexually transmitted disease bureau of the department; (4) the director of the epidemiology division of the department or his designee; (5) a medical officer of the public health division of the department; and (6) other persons or representatives as chosen by the secretary of health to ensure a thorough and unbiased evaluation of the program established under the Harm Reduction Act. C. The advisory committee shall: (1) develop policies and procedures for evaluation of the harm reduction program; (2) develop criteria for data collection and program evaluation; and (3) meet as necessary to analyze data and monitor and produce a report on the harm reduction program. D. The department may contract with private providers to operate the program. History: Laws 1997, ch. 256, § 4.